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1. Introduction 
Over the past 40 years, the advent of more effective treatment regimens has transformed 
vasculitis from a frequently fatal, acute disease to a chronic condition with relapsing and 
remitting episodes with which patients can live for many years. Because vasculitis is now 
viewed as a chronic disease, the role of treatment has expanded from an almost exclusive 
focus on reducing mortality and inducing remission to include improving patient quality of 
life. In fact, most research studies with vasculitis patients, including clinical trials and 
observational studies, now measure patient quality of life to determine what factors hinder 
and facilitate optimal patient functioning and well-being. 
The World Health Organization has defined quality of life as “individuals’ perception of 
their position in life in the context of the culture and value systems in which they live and in 
relation to their goals, expectations, standards and concerns” (WHO, 1997, p. 1). Implicit in 
this definition is the fact that many layers of influence, ranging from intrapersonal beliefs to 
environmental factors, affect quality of life. In chronic disease populations, researchers often 
focus on patient health-related quality of life (HRQOL). Although HRQOL is more narrowly 
focused than quality of life, it is a still a complex concept that refers to the overall perceived 
well-being of an individual as well as his/her ability to function in daily life (Hays et al., 
1993). There are many definitions of HRQOL, but most scholars agree that HRQOL includes 
both multidimensional and subjective components (Cella, 1994). The multidimensional 
component refers to the many dimensions (e.g. physical, functional, emotional, financial, 
and social) on which chronic disease can affect the patient’s health and functioning. The 
subjective component suggests that patients, rather than health care providers, for example, 
are in the best position to report their HRQOL. 
Although the HRQOL literature has primarily described how vasculitis negatively impacts 
patients’ physical and mental health, there is also some evidence that patients experience 
positive impacts. Moreover, in addition to directly affecting the patient, vasculitis also has 
the potential to influence patients’ relationships with spouses, family members, and friends. 
Garnering a holistic understanding of how vasculitis affects patients and their social 
networks is of interest because individuals having a chronic disease often seek support from 
others to help cope with disease-related stressors, which can lead to improved physical and 
mental health (Pennix et al., 1996).  
This chapter not only describes how vasculitis positively and negatively impacts patients’ 
HRQOL, but also, the impacts of vasculitis on members of patients’ social networks. We first 
focus on patient HRQOL issues, including an examination of how vasculitis affects patients 
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physically, functionally, psychologically, and financially. Next we describe how vasculitis 
impacts patients’ social quality of life, including relationships with spouses, family, and 
friends. Last, we propose areas for future research and offer conclusions. 
2. Patient quality of life issues 
We identified 21 articles that have been published in English and primarily describe the 
HRQOL of vasculitis patients (Table 1). Taken together, these articles demonstrate that 
vasculitis negatively affects patients physically, functionally, psychologically, financially, 
and socially. Table 1 provides a brief overview of the articles, including the study design, 
subjects, and domains of quality of life assessed. In this section, we summarize the results of 
these studies by quality of life domain. Social quality of life is described in Section 3 “Impact 
on patients’ relationships with social network members.” 
 
Study Design Subjects Domains of 
quality of life 
assessed 
Abdou et al., 2002 Cross-sectional Granulomatosis with 
polyangiitis (GPA) 
(n= 701)
 Physical 
 Financial 
Abularrage et al., 
2008 
Cross-sectional Takayasu’s arteritis
(n= 158) 
 Physical 
 Psychological 
 Functional 
 Financial 
 Social 
Akar et al., 2008 Cross-sectional 
case-control 
Takayasu’s arteritis
(n= 51) 
 Physical 
 Functional 
 Psychological 
Basu et al., 2010 Cross-sectional 
case-control 
ANCA-associated 
vasculitis (n=74) 
 Physical 
 Psychological 
Bernabé et al., 
2010 
Cross-sectional Behçet’s disease (n= 362)  Physical 
 Psychological 
Boomsma et al., 
2002 
Cross-sectional 
case-control 
Granulomatosis with 
polyangiitis 
(n =79) 
 Functional 
 Psychological 
 Financial 
 Social 
Carpenter et al., 
2009 
Cross-sectional ANCA-associated 
vasculitis (n= 97) 
 Physical 
 Functional 
 Psychological 
Carpenter et al., 
2011 
Cross-sectional Multiple vasculitis types
(n=228) 
 Physical 
 Functional 
 Psychological 
Table 1. Summary of quality of life studies conducted with vasculitis patients 
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Study Design Subjects Domains of 
quality of life 
assessed 
Ertam et al., 2009 Cross-
sectional case-
control 
Behçet’s disease (n= 195)  Physical 
 Functional 
 Psychological 
Faurschou et al., 
2010 
Cross-
sectional case-
control 
Granulomatosis with 
polyangiitis 
 (n=68) 
 Physical 
 Functional 
 Psychological 
Hajj-Ali et al., 
2011 
Cross-
sectional 
Granulomatosis with 
polyangiitis 
 Psychological 
Hellmann et al., 
2003 
Cross-
sectional 
Giant cell arteritis (n= 145)  Physical 
 Functional 
 Psychological 
Herlyn et al., 1998 Longitudinal 
case-control 
Multiple vasculitis types 
(n=303) 
 Physical 
 Functional 
 Psychological 
Hoffman et al., 
1998 
Cross-
sectional 
Granulomatosis with 
polyangiitis 
(n= 60) 
 Physical 
 Functional 
 Psychological 
 Financial 
 Social 
Koutantji et al., 
2003 
Cross-
sectional 
ANCA-associated vasculitis 
(n= 50) 
 Physical 
 Functional 
 Psychological 
Moses Alder et 
al., 2008 
Cross-
sectional case-
control 
Behçet’s disease (n= 129)  Physical 
 Functional 
Mumcu et al., 
2006 
Cross-
sectional case-
control 
Behçet’s disease (n= 94)  Physical 
 Functional 
 Psychological 
Newall et al., 
2005 
Cross-
sectional 
ANCA-associated vasculitis 
(n= 30) 
 Physical 
 Psychological 
Reinhold-Keller 
et al., 2002 
Cross-
sectional 
Granulomatosis with 
polyangiitis 
(n= 60) 
 Physical 
 Functional 
 Psychological 
 Financial 
Srouji et al., 2008 Cross-
sectional 
Churg-Strauss Syndrome 
(n= 25) 
 Physical 
Uguz et al., 2007 Cross-
sectional 
Behçet’s disease (n= 50)  Physical 
 Psychological 
 Social 
Table 1. continued 
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2.1 Physical and functional quality of life 
Of all the HRQOL domains, the physical domain has been best described for vasculitis 
populations. Physical quality of life can be directly affected by vasculitis symptoms, organ 
system damage, and treatment-related morbidities such as side effects and drug toxicity 
(Buhaescu et al., 2005; Exley & Bacon, 1996). Interestingly, physician-rated disease activity 
scores, such as the Birmingham Vasculitis Activity Score and the Vasculitis Damage Index 
(Flossmann et al., 2007), have been weakly correlated with patient HRQOL (Koutantji et al., 
2003; Basu et al., 2010). This finding reinforces that quality of life cannot be reduced to 
biological effects of the disease and that accounting for other factors is important.  
Physical HRQOL has commonly been assessed using scores from the four physical health 
subscales of the SF-36 (Ware & Kosinski, 2005). These include physical functioning, role 
limitations due to physical health, bodily pain, and general health. Although fatigue is 
sometimes categorized as a psychological quality of life issue, we include it here because it 
is a physical symptom of vasculitis that has been significantly correlated with the physical 
health component score (Ware & Kosinski, 2005). Thus, this section will describe fatigue, 
pain, and physical changes. Physical functioning and role limitations due to physical health 
are discussed in the functional quality of life section (Section 2.2).  
2.1.1 Fatigue 
Fatigue is a major problem affecting the quality of life of vasculitis patients. In studies using 
the SF-36, energy/vitality was one of the most consistently, negatively affected SF-36 
subscales. Four studies have shown that over 75% of patients report problems with 
vasculitis-related fatigue (Abularrage et al., 2010; Bernabé et al., 2010; Hajj-Ali et al., 2011; 
Hoffman et al., 1998). More specifically, Basu and colleagues (2010) found that patients were 
more than twice as likely as controls to report mild/moderate and severe fatigue; and 
fatigue was a stronger predictor of worse physical health than disease activity.  
Herlyn and colleagues (2010) found that fatigue and reduced energy levels were the most 
important patient-reported disease burden. One reason fatigue may be so important to 
vasculitis patients is that it can negatively impact other domains of quality of life by reducing 
the amount of energy patients have to engage in social activities and limiting patients’ ability 
to fulfill important work- and home-related roles. Hajj-Ali and associates (2011) found that 
almost half of vasculitis patients believed that fatigue significantly limited their activities.  
2.1.2 Pain 
The results regarding pain have not been as consistently negative as those for fatigue. 
Although most studies have found that vasculitis patients report more bodily pain than 
national norms or healthy controls, two studies report results to the contrary. Specifically, 
Carpenter and colleagues (2009) and Faurschou and associates (2010) documented that bodily 
pain was not significantly different for vasculitis patients when compared with national norms 
or age and sex-matched controls, respectively. However, Carpenter et al. (2011) found that 
bodily pain was worse for relapsing patients than for those in remission. Thus, mixed results 
may partially be due to the proportion of patients in relapse versus remission in any given 
sample; the Faurschou et al. (2010) sample included only patients with inactive vasculitis. 
Also, both studies consisted primarily of Granulomatosis with polyangiitis (GPA; formerly 
Wegener’s) patients, and pain may be a greater issue for other types of vasculitis. 
Kountantji and associates (2003) have conducted more thorough analyses of how pain 
affects GPA patients. They found that patients in greater pain reported significantly worse 
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quality of life when compared to patients who reported little or no pain. Also, patients in 
greater pain experienced more problems with depression, fatigue, and sleep. Moreover, 
patients with significant pain had more severe role limitations due to physical health than 
patients in less pain. Moses Alder and colleagues (2008) also found that Behçet’s (BD) 
patients with arthritis reported more pain than patients without arthritis. 
2.1.3 Physical changes 
In addition to fatigue and pain, vasculitis symptoms and organ damage can negatively 
impact patient quality of life. Hearing loss, headaches, shortness of breath, and comprised 
kidney function are some examples of how vasculitis affects patients physically (Langford, 
2005; Seo et al., 2005). In some cases, vasculitis can directly alter a patient’s physical 
appearance by causing weight loss or nasal bridge collapse, otherwise known as saddle nose 
deformity. Patients may also experience skin problems, such as ulcers or purpura (i.e. a rash 
of purple spots). Readers who are interested in learning more about vasculitis and organ 
system damage are referred to articles by Seo and colleagues (2005) and Langford (2005). 
Vasculitis medications can also cause changes to a patient’s physical appearance. For 
example, patients who are treated with steroids often report weight gain and a condition 
called moon face, where the face swells into a rounded shape. Patients treated with 
immunosuppressive medications also report hair loss, hair growth, acne, and mouth sores. 
Although side effects like these are physical in nature, they can also take a toll on patients 
psychologically by adversely affecting their self-esteem. Thus, it is important to account for 
physical changes due to the disease itself as well as treatment-related effects when 
considering physical quality of life for vasculitis patients.  
2.2 Functional quality of life 
Functional quality of life is intimately related with physical quality of life and is commonly 
considered part of the physical domain. In this chapter, we dedicate a separate section to 
functional quality of life to specifically focus on how vasculitis affects patients’ ability to 
engage in activities of daily living, such as bathing and completing household chores. Most 
studies have captured functional quality of life issues with the physical functioning subscale 
of the SF-36 (Ware & Kosinski, 2005). The physical functioning scale contains 10 items that 
ask how limited patients are in conducting a range of physical activities, from bending and 
kneeling to running and lifting heavy objects.  
Overall, research using the SF-36 has shown that vasculitis patients have worse physical 
functioning when compared with healthy controls or national norms. In two cases, physical 
functioning was the most negatively affected of the eight SF-36 dimensions (Herlyn et al., 
1998; Koutantji et al., 2005). Furthermore, the physical changes associated with vasculitis, 
including pain and fatigue, often led to increased role limitations. For example, patients 
often have to cut down the amount of time they spend on work or have to exert extra effort 
to engage in activities of daily living. 
Other studies have provided more detail about the extent to which vasculitis negatively 
impacts patients’ ability to engage in activities of daily living. For example, Hoffman and 
colleagues (1998) found that 56% of Granulomatosis with polyangiitis (GPA) patients 
reported moderately or severely compromised activities of daily living. Similarly, two-thirds 
of GPA patients reported that vasculitis had negatively affected their ability to perform 
everyday activities, with many patients noting that the disease had a stronger impact on 
their physical functioning at the time of diagnosis (Boomsma et al., 2002). Moreover, daily 
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activities, like being able to shower, shave, chew, and walk without difficulty or losing 
balance, were all ranked among the top ten most important quality of life issues for patients 
living with giant cell arteritis (Hellmann et al., 2003), while patients with Behçet’s disease 
noted negative changes to their ability to engage in usual activities and mobility (Ertam et 
al., 2010). Additionally, patients who were unemployed (Reinhold Keller et al., 2002), had 
active disease (Mumcu et al., 2006; Ertam et al., 2009), or were in more pain (Koutantji et al., 
2003) were more likely to report greater physical role limitations.  
2.3 Psychological quality of life 
Most of the studies listed in Table 1 used the SF-36 (Ware & Kosinski, 2005) to measure 
psychological quality of life. The SF-36 contains four subscales, including social functioning, 
energy/vitality, role limitations due to emotional health, and mental health, which load on a 
summary mental health component score. Overall, SF-36 results reveal that vasculitis 
patients experience compromised psychological health. A more in-depth discussion of 
psychological aspects of vasculitis appears in an editorial by Koutantji and colleagues 
(2000). We save the discussion of social functioning issues until Section 3, which summarizes 
the impact of vasculitis on patients’ relationships with social network members. 
2.3.1 Depression and anxiety 
It is common for patients living with chronic disease to experience feelings of depression 
and anxiety. Because depression is associated with many other negative sequelae, including 
worse treatment adherence (DiMatteo et al., 2000), it is important to assess the mental health 
of vasculitis patients. An examination of the mental health subscale results from studies that 
used the SF-36 shows that mental health is generally lower for vasculitis patients than either 
healthy controls or the general U.S. population. There are some exceptions to this as a few 
studies have found that vasculitis patients did not differ significantly from controls in terms 
of mental health (Basu et al., 2010; Koutantji et al., 2003). These mixed results may be due to 
differences in study populations. Because few studies have provided a more detailed 
description of depression and anxiety in vasculitis populations, little is known about what 
factors may moderate depression or which patients are most at risk. As we will describe 
below, preliminary results indicate that depression and anxiety are serious issues for 
patients that warrant further examination.  
Depression and anxiety are problems for vasculitis patients regardless of the type of 
vasculitis with which they have been diagnosed. To illustrate, Hajj-Ali and colleagues (2011) 
discovered that the prevalence of depression in GPA patients was much higher than the 
general population; 23.6% and 7.6%, respectively. Other studies have documented that 
between 33% and 43% of GPA patients report disease-related depression, with 7% to 14% 
reporting depression associated with suicidal thoughts (Hoffman et al., 1998; Boomsma et 
al., 2002). Similarly, Bernabé and colleagues (2010) found that 60% of Behcet’s patients noted 
problems with depression and anxiety, and Koutantji and associates (2003) documented that 
fully 43% of patients reported increased anxiety and 25.5% experienced increased 
depressive symptoms. 
2.3.2 Other psychological impacts 
Unfortunately, other than depression and anxiety, there is not much published information 
about how vasculitis impacts patients psychologically. In fact, some of the other 
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psychological variables examined are conceptually related to depression and anxiety (e.g., 
happiness and stress, respectively) but are sufficiently distinct to warrant a separate 
discussion. Regarding happiness, 32% of GPA patients were unhappy because of their 
vasculitis (Boomsma et al., 2002), while 52% of Takayasu’s arteritis (TA) patients reported 
being less happy overall (Abularrage et al., 2008). One study has documented that over half 
of GPA patients reported problems with stress (Abdou et al., 2002), suggesting that further 
examination of stress and vasculitis is justified. In addition, although positive effects of 
vasculitis are reported less frequently than negative effects, there appears to be a subset of 
patients who describe beneficial changes that result from a vasculitis diagnosis. Because 
vasculitis exacts a negative toll physically, functionally, and financially, the majority of these 
positive effects are seen in the psychological and social domains. For example, Abularrage 
and colleagues (2008) have found that 11% of TA patients reported an improvement in 
overall happiness and 12% reported an improvement in overall mood. No analysis was 
presented of differences between patients reporting positive effects versus those who 
reported negative or no effects; thus, we do not know whether other factors moderated the 
effect of vasculitis on patients’ psychological responses.  
We have unpublished qualitative survey data from a sample of 232 patients that offers some 
preliminary evidence as to why some patients report positive changes to their mood. In our 
study, patients commonly discussed how they reevaluated their lives and priorities after 
receiving a vasculitis diagnosis. Patients who recovered from a particularly bad relapse often 
described how they now appreciated every day and considered each moment precious. This 
reevaluation led patients to feel calmer and to not become stressed by minor inconveniences 
that used to bother them. Improvements in relationships with family members were also 
commonly reported, which may decrease patients’ psychological distress.  
2.4 Financial quality of life 
Very few studies have explored the economic burden of vasculitis. Using hospital records 
from 1986-1990, Cotch (2000) estimated that the costs of vasculitis-related hospitalizations 
alone were $150 million per year in the United States. Although the author could not 
account for other direct medical costs, such as medication and physician visit expenses, and 
indirect costs due to changes in employment, it is reasonable to assume that vasculitis-
related expenditures are substantial and negatively impact patients and their families 
(Herlyn et al., 2010). Five studies provide greater detail about the financial impact of 
vasculitis; they are summarized below. 
Four studies have documented employment issues for Granulomatosis with polyangiitis 
(GPA) patients. In the first study, Hoffman and colleagues (1998) found that most patients 
(80%) were employed at the time of their vasculitis diagnosis; however, total household 
income was reduced by approximately 25%. Income reductions may have been due to 
patients’ having to take at least 6 consecutive weeks of sick leave, receiving temporary 
disability status, or modifying their jobs. Similarly, Boomsma and associates (2002) found 
that GPA patients frequently missed work due to their disease, changed work duties, 
reduced work hours, and in rare cases (5%), had to resign from their jobs. Given these job-
related changes, it is not surprising that 23% of patients reported a disease-related income 
reduction. A third study also found that patient financial quality of life was disrupted by 
vasculitis (Abdou et al., 2002). Specifically, 54% of patients reported losing 25% to 75% of 
their income, with almost half spending between $10,000 and $100,000 on their therapy and 
diagnosis. Additionally, 14% of patients reported having to retire due to their illness. In 
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addition, a study conducted by Reinhold-Keller and colleagues (2002), found that 27% of 
GPA patients were permanently unemployed as a result of their vasculitis and that women 
had a three-fold greater risk than men of losing their jobs. Patients who were employed 
reported missing a median of 14 days of work during the past year due to their vasculitis. 
The fifth financial quality of life study involved Takayasu’s arteritis (TA) patients 
(Abularrage et al., 2008). Almost half of those patients changed their work duties due to 
their TA. Additionally, approximately half of patients reported changing work hours and 
missing more than six consecutive weeks of work, while almost a third reported taking 6 
consecutive months of sick leave from work. Moreover, TA caused almost a quarter of 
patients to resign from work and 15% to retire.  
3. Impact on patients’ relationships with social network members 
Relatively little is known about the ways in which vasculitis impacts patients’ relationships 
with spouses, family members, and friends. Many of the studies listed in Table 1 have 
measured social quality of life using the SF-36 (Ware & Kosinski, 2005), which includes two 
items about how the patient’s physical health and emotional problems have interfered with 
his/her ability to engage in social activities. Overall, the results from these studies show that 
patient social functioning is compromised; however, the SF-36 social functioning items are 
so general that they offer limited utility in understanding how social relationships and 
activities have been affected. In this section, we will summarize existing research about the 
social impact of vasculitis as well as draw upon research from other disease populations to 
explain how a chronic, unpredictable illness like vasculitis can strain or enhance patients’ 
relationships. We focus on the three studies that have documented social relationship issues 
in greater detail; Table 2 summarizes the results of these studies. 
 
Relationship Effect 
Study 
Hoffman et al., 
1998 
Boomsma et al., 
2002 
Abularrage et al., 
2008 
Spouse/Partner    
No effect 25% 71% 44% 
Improved relationship 56% 20% 36% 
Worsened relationship 19% 9% 29% 
    
Family    
No effect 40% 74% 35% 
Improved relationship 47% 16% 41% 
Worsened relationship 12% 10% 23% 
  
Friends  
No effect 65% 70% - 
Improved relationship 14% 7% - 
Worsened relationship 21% 23% - 
Table 2. Percentage of patients reporting vasculitis-related effects on their relationship with 
their spouse/partner, family, and friends 
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3.1 Impact on spousal relationships 
Chronic illness is a stressor that can affect the physical health and psychological well-being 
of patients as well as their spouses/partners (Baanders & Heijmans, 2007; Berg & Upchurch, 
2007). Much of the stress that spouses experience may result from adapting to a new role as 
the patient’s primary caregiver. For example, Marks and associates (2002) have shown that 
transitioning to a caregiving role increases depression in spouses of chronic disease patients. 
Vasculitis may be particularly mentally taxing for couples because spouses must be ready to 
act as a caregiver each time the patient experiences a relapse or disease flare-up. Because the 
severity of relapses varies considerably, the physical demands of caregiving for any 
particular relapse may range from minor to substantial, which requires additional 
adjustment on the part of the spouse. Moreover, patients often want to avoid being a burden 
on the caregiver, which can complicate interpersonal interactions as patients adapt to the 
sick role. These issues are discussed in greater detail by Koutantji and associates (2000). 
Of the three studies that investigated the effect of vasculitis on spouse/partner 
relationships, two were conducted with Granulomatosis with polyangiitis (GPA) patients 
(Hoffman et al., 1998; Boomsma et al., 2002) and another was conducted with Takayasu’s 
arteritis (TA) patients (Abularrage et al., 2008). The results from these studies reveal 
substantial variation in the extent to which vasculitis affects spousal relationships (Table 2). 
For example, in the two studies of GPA patients, the percentages of patients who reported 
that vasculitis did not affect their relationship with their spouse were 25% and 71%. The 
percentage of TA patients reporting no effect was in the middle (44%) of the previous two 
estimates. In all three studies, patients were more likely to report that vasculitis had 
improved, rather than worsened, their relationship with their partner. Unfortunately, 
greater detail about how relationships improved has not yet been reported. Based on some 
Qualitative data patients and their partners have shared with us, positive effects may 
include: 1) feeling closer to one another, 2) more equal distribution of household labor, and 
3) making one’s relationship a priority after experiencing a severe relapse (Carpenter et al., 
under review). 
There is also little insight into how relationships with partners have worsened; however, 
both GPA studies found that about 70% of spouses were concerned about the long-term 
effects of vasculitis and its treatment and approximately one-third were concerned about 
how vasculitis will affect their financial security. Additionally, Hoffman noted that spouses 
sometimes had to alter their employment situation in order to care for the patient. Thus, it 
seems that emotional strain (e.g. worry and concern) as well as financial strain may take a 
toll on marriages. While these additional strains did not lead divorced GPA patients to 
believe vasculitis was the cause of their divorce (Hoffman et al.; 1998), 37% of TA patients 
believed their vasculitis was largely responsible for the termination of their relationship 
(Abullarage et al.; 2008). Although this has not been reported in the literature, qualitative 
data from our Accessing Social Support in Symptom Treatment (ASSIST) Study reveals that 
patients’ sex lives are often negatively impacted. Moreover, patients often report partners’ 
becoming frustrated with mood swings that are a side effect of certain vasculitis 
medications. 
The negative impact of vasculitis on marriages may be markedly reduced if couples learn 
how to effectively manage and cope with vasculitis dyadically, as discussed by Lewis and 
colleagues (2006). Specifically, patients and their partners may minimize the negative effect 
of vasculitis on HRQOL through communal coping, developing a high level of dyadic 
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efficacy, and effective communication (see Lewis et al. for a more thorough discussion of 
these topics). Effective dyadic coping may explain why spouses of vasculitis patients did not 
report a lower HRQOL when compared with the general U.S. population, even though the 
HRQOL of patients and spouses was moderately correlated, meaning that spouses were 
more likely to report reduced HRQOL if the patient did (Carpenter et al., 2009). 
3.2 Impact on family relationships 
As shown in Table 2, it was uncommon for patients to think that vasculitis negatively 
impacted relationships with family members. Although 74% of participants in the Boomsma 
et al. study believed that relationships with family were unaffected, between 40% and 50% 
of patients from the other two studies felt that their family relationships had improved. 
Again, details about how relationships had improved were not provided. It is likely that a 
serious life-threatening illness like vasculitis can cause patients to feel closer to their family, 
especially if they are emotionally and instrumentally supportive when the patient is 
experiencing a relapse. Indeed, qualitative data from the ASSIST Study supports this 
statement, with many patients reporting that they feel closer to family members, either 
through family members’ increasing the frequency with which they interact with patients or 
telling the patient how concerned they are for the patient’s well-being. 
In all three studies, fewer than 25% of patients reported negative changes to family 
relationships. Between 5 and 10% of non-spousal family members of GPA patients changed 
their employment status in order to care for the patient, whereas 18% of family members of 
TA patients altered their work situation. Relationships are probably most at risk when a 
family member, like a child or parent, takes on a caregiving role, as those family members 
are under additional physical, mental, and financial strain.  
3.3 Impact on friendships 
Of the three relationships discussed in this chapter, friendships are the most likely to be 
negatively impacted by vasculitis. Although two studies in Table 2 document that 
approximately 20% of patients reported that vasculitis had worsened their friendships, a 
recent qualitative study has found that more than half of vasculitis patients experienced 
degradation in the quantity and quality of their friendships (Carpenter et al., under review). 
To be specific, 1 in 5 patients reported losing a friend as a result of their vasculitis diagnosis. 
Moreover, quality of friendships was compromised due to reduced social participation, with 
25% of patients engaging in fewer social activities after their diagnosis. Reduced social 
participation was often attributed to friends’ lack of understanding about vasculitis, 
vasculitis-related fatigue, lifestyle changes related to medication contraindications and 
infection precautions, as well as patient withdrawal. 
Although previous research has found that between 7% and 14% of patients report that 
vasculitis led to improved friendships, more than 45% of patients reported positive 
friendship changes in the study by Carpenter and colleagues. Positive changes included 
becoming closer with friends and receiving social support. Supportive friends were 
described as those who showed some interest in vasculitis and its effects, understood and 
accepted that patients would not be able to engage in social activities at the same level as 
previous to illness onset, and were emotionally and instrumentally supportive. Many times, 
patients developed new friendships with other chronic disease patients. These relationships 
helped patients realize they were not alone and often became an avenue for sharing 
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personal accounts of the disease as well as helpful disease-specific information that patients 
were unable to get elsewhere. 
4. Limitations of existing research 
Table 1 highlights several methodological limitations in the HRQOL literature that are 
worthy of greater discussion. First, all but one of the HRQOL studies was cross-sectional in 
nature. Without longitudinal data, we cannot determine how HRQOL changes over time, 
which may be particularly important for a relapsing, remitting disease like vasculitis. 
Furthermore, cross-sectional studies limit our ability to identify moderators or mediators of 
the effect of vasculitis on HRQOL. Disease status, or whether a patient is in relapse or 
remission, is likely one such moderator. Preliminary evidence demonstrates that: 1) 
remission status was the only significant predictor of better mental quality of life for 
Takayasu’s arteritis patients (Abularrage et al., 2008) and, 2) relapsing patients reported 
lower quality of life for 7 of 8 SF-36 subscales when compared with patients in remission 
(Carpenter et al., 2011). Other potential moderators include number of comorbidities (Ertam 
et al., 2009), whether the patient is taking immunosuppressive medications (Faurschou et al., 
2010), vasculitis type (Koutantji et al., 2003), and patient age (Faurschou et al., 2010). 
Additionally, patient coping (Koutantji et al., 2000) and social support (Carpenter et al., 
2011) may mediate the relationship between vasculitis and HRQOL. 
A second limitation concerns the measurement of health-related quality of life. For example, 
the majority (79%) of studies used generic measures of HRQOL, including the Short Form 36 
(SF-36; Ware & Kosinski, ), the World Health Organization’s WHOQOL-100 (WHO, 1997), 
and the EQ-5D (EuroQol group, 1990). Only a few studies (26%) used disease-specific 
measures, such as the quality of life questionnaire developed specifically for vasculitis 
patients by Hoffman and colleagues (Hoffman et al., 1998). The rationale for these choices is 
not always clear. Measurement is the link between the concepts and variables researchers 
want to examine and the numbers they collect and analyze. Unless the correspondence 
between the measures and the concepts is high, the numbers may be subject to 
misinterpretation. Under some circumstances, for example, illness-specific concepts and 
variables may be of interest. For example, the uncertainty patients with relapsing/remitting 
illnesses face may expose them to forms of stress that may not be a part of other chronic 
illnesses with a less variable trajectory. When that is the case, using a less specific 
assessment tool may not fully capture the concept of interest to the researcher. On the other 
hand, when investigators wish to examine the same variables across different conditions, 
using illness-specific measures may impede their ability to do so. Another important 
measurement distinction that is often overlooked differentiates measures comprising 
indicators sharing a common cause from those sharing a common effect. As an example, 
most depression scales fit a common-cause model, with the response to each item being 
determined by the same subjective state experienced by the respondent. In contrast, 
comorbidity checklists typically aggregate variables that have a common effect (i.e., each 
contributes a quantum of poor health to a total) but that do not necessarily share a common 
cause (i.e., the various comorbid conditions may not share a common etiology). Certain 
measurement procedures are more readily applicable to the common-cause than to the 
common-effect situation and some psychometric procedures, such as the computation of 
internal-consistency reliability, are inappropriate for measures based on common effects 
(e.g., DeVellis, 2012). More generally, it is essential that sufficient attention is paid to 
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measurement issues to ensure that the information gathered accurately reflects the precise 
nature of the variables the investigators intend to quantify. 
Third, although there are over 15 types of vasculitis, quality of life has been reported for 
only six different vasculitis types: ANCA-associated (Granulomatosis with polyangiitis, 
Churg-Strauss Syndrome, Microscopic polyangiitis), Takayasu’s arteritis, giant cell arteritis, 
and Bechet’s disease. GPA and Behçet’s disease have received the most attention in the 
literature thus far. Because recruiting patients with a rare illness is often costly and 
logistically difficult, researchers’ ability to describe HRQOL is limited, especially with rarer 
forms of vasculitis. Difficulties with recruitment are why many studies included fewer than 
100 patients. Vasculitis researchers must strike a balance recruiting larger convenience 
samples versus using smaller randomly-selected samples. 
Last, most research to date has focused on physical, functional, and psychological quality of 
life, with fewer studies investigating financial and social domains. To garner an 
understanding of how vasculitis affects patients’ total well-being requires more data about 
non-physical consequences of the disease. Simply documenting the percentage of patients 
experiencing positive, negative, or no changes in these life domains is not enough to make 
concrete recommendations for how to enhance patient care. For example, more information 
about how social relationships have changed is needed to identify how family members can 
help patients manage the physical and emotional burden of vasculitis.  
5. Future research directions 
In attempting to summarize the vasculitis quality of life literature, we have identified 
several areas for future research. First, as noted in the previous section, we believe 
longitudinal studies are needed to help identify important moderators and mediators of the 
effect of vasculitis on patient quality of life. Longitudinal studies could be conducted in a 
cost-effective manner using web-based surveys. Carpenter and colleagues (2011) had a 98% 
retention rate for a 3-month, web-based longitudinal study of vasculitis patients. Although 
Internet-based studies are subject to selection bias, as the number of patients using the 
Internet continues to increase, selection bias will become less of an issue. 
We also endorse mixed methods studies that qualitatively and quantitatively ascertain 
patients’ quality of life. Qualitative studies would help illuminate how patients are 
positively affected by vasculitis and reveal quality of life domains that are untapped by 
existing measures. For example, even though we know that vasculitis and its treatment can 
affect patients’ sex drive and fertility (Seo, 2007), no studies have documented how these 
issues are related to patients’ psychological and social health. Telephone interviews may be 
the most feasible method for collecting in-depth qualitative data on these topics, though 
focus groups conducted at patient support groups or conferences may yield qualitative data 
on less sensitive topics, like positive effects of the disease. 
Finally, greater attention to measurement issues would be beneficial. As mentioned earlier, 
measurement is a vital link between what investigators intend to learn and the actual data 
their studies produce. It is incumbent on investigators to explain why their measures have 
been chosen. Unfortunately, the only justification offered in some studies is that the 
instrument used was a “validated scale.” In fact, neither reliability nor validity are 
properties of a scale per se, but of how a scale is used. Thus, a demonstration of a scale’s 
validity in one instance does not guarantee it in a separate instance, especially if the two 
differ in important ways.  
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6. Conclusion 
Although we have discussed several domains of HRQOL individually, they are inter-
related. Physical health influences mental health, which is also affected by social functioning 
and the patients’ financial situation. Together, these components make up the 
multidimensional construct of HRQOL. Between the years of 2000 and 2010, we have seen a 
marked increase in the number of studies that document quality of life issues for vasculitis 
patients. These studies show that vasculitis impairs patient quality of life in every domain 
but offer little insight into the mechanisms through which the disease affects patients 
psychologically and socially. The challenge for researchers is to build upon this base of 
studies and draw theoretical insights from research with other chronic diseases to identify 
areas where the negative impact of the disease can be reduced. During the coming years, we 
are confident that additional quality of life studies will better describe how vasculitis 
positively and negatively influences the quality of life of patients and their social network 
members. Additionally, we foresee that the field will shift from a focus on describing quality 
of life to developing non-medical interventions to improve quality of life. 
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